| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2003101932A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003082777A3 Novel glucocorticoid receptor ligands |
| 04/01/2004 | WO2003064617A3 Pestalotiopsis microsporia isolates and compounds derived therefrom |
| 04/01/2004 | WO2003048147A3 PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES |
| 04/01/2004 | US20040063975 Antiinflammatory agents; antiischemic agents; central nervous system disorders; prevent tissue degradation |
| 04/01/2004 | US20040063968 Process for use in 11-oxa prostaglandin synthesis |
| 04/01/2004 | US20040063963 Dimerization; oxidation coupling of naphthol in presence of complex catalyst of copper chloride-tetramethylethylenediamine |
| 04/01/2004 | US20040063959 Esters and amides as PLA2 inhibitors |
| 04/01/2004 | US20040063882 (Meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063780 Pharmaceutical preparations for treatment of type II diabetes and methods for treatment of type II diabetes |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063765 Modulation of pathogenicity |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040060809 Method for the production of phthalic anhydride to a specification |
| 04/01/2004 | CA2499655A1 Continuous process for the production of optically pure (s)-.beta.-hydroxy-.gamma.-butyrolactone |
| 04/01/2004 | CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | CA2499213A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | CA2496386A1 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases |
| 03/31/2004 | EP1403295A2 Ester compounds, polymers, resist compositions and patterning process |
| 03/31/2004 | EP1403262A1 Process for producing optically active alpha butyrolactone |
| 03/31/2004 | EP1402890A1 Sulfonamide derivatives |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1401824A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 03/31/2004 | EP1401822A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 03/31/2004 | EP1401806A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 03/31/2004 | EP1401575A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 03/31/2004 | EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 03/31/2004 | EP1401427A2 Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them |
| 03/31/2004 | EP1301501B1 Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect |
| 03/31/2004 | EP1181294B1 Novel derivatives and analogues of galanthamin |
| 03/31/2004 | EP1021439B1 Crystalline antifungal polymorph |
| 03/31/2004 | CN1485323A 5-nitrobenzofurans |
| 03/31/2004 | CN1485322A Method for producing tetrahydrofuran |
| 03/31/2004 | CN1485304A One-step production of high-purity trimellitic acid from pseudocumene |
| 03/31/2004 | CN1143679C Method and material for treating and preventing mucosal tissue inflammation |
| 03/30/2004 | US6713639 Process for preparing enantiomerically pure (S)-3-hydroxy-gamma-butyrolactone |
| 03/30/2004 | US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
| 03/30/2004 | US6713507 Ether compounds and compositions for cholesterol management and related uses |
| 03/30/2004 | US6713435 Method for producing optically active lactone compounds by using salen cobalt complexes having a cis-β structure |
| 03/30/2004 | US6713290 Generating preferential particle; incubate starch and oligosaccharide, oxidize mixture, cyclize mixture, recover preferential compound |
| 03/30/2004 | US6713059 Antibodies raised against immunogenic conjugates of gram-negative bacterial autoinducer molecules |
| 03/30/2004 | CA2278687C 5-aroylnaphthalene derivatives |
| 03/30/2004 | CA2215470C Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
| 03/30/2004 | CA2123885C Insecticidal phenylhydrazine derivatives |
| 03/25/2004 | WO2004024878A2 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/25/2004 | WO2004024737A1 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms |
| 03/25/2004 | WO2004024707A2 Process for preparing amine type substituted benzofurans |
| 03/25/2004 | WO2004024688A1 Substituted spirocyclic ketoenols |
| 03/25/2004 | WO2004023872A2 High concentration topical insecticide |
| 03/25/2004 | WO2003086287A3 Compounds and methods for inducing apoptosis in proliferating cells |
| 03/25/2004 | WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 03/25/2004 | WO2003069350A3 Small molecule modulators of apoptosis |
| 03/25/2004 | WO2003060852A3 Catalytic osmium-assisted oxidative cleavage of olefins |
| 03/25/2004 | WO2003041728A8 Novel phenyl-propargylether derivatives |
| 03/25/2004 | WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 03/25/2004 | US20040058990 Thrombopoietin mimetics |
| 03/25/2004 | US20040058989 Solid dosage form; antidepressant |
| 03/25/2004 | US20040058968 Antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
| 03/25/2004 | CA2498936A1 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/25/2004 | CA2498181A1 High concentration topical insecticide |
| 03/24/2004 | EP1400516A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage |
| 03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399406A2 Novel estrogen receptor ligands and methods i |
| 03/24/2004 | EP1399163A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 03/24/2004 | EP1399159A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2004 | EP1399146A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1144400B1 Production of aqueous solutions of mixtures of formyltetrahydrofuran and hydrates thereof |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | EP0904079B1 Antidiabetic agents |
| 03/24/2004 | CN1484528A Pharmaceutical composition comprising wikstromol and/or mataires inal, its use as hepatoprotectant and process for their isolation from cedurs deodara |
| 03/24/2004 | CN1484523A Pharmaceutical composition containing citalopram |
| 03/24/2004 | CN1483730A 'Beta'-substituted-'gamma'-butyrolactone |
| 03/24/2004 | CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/24/2004 | CN1142926C Method for preparing citralopram |
| 03/24/2004 | CN1142925C Method of preparation of maleic anhydride |
| 03/23/2004 | US6710208 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and α,β-unsaturated carboxylic acid and aldehyde compounds |
| 03/23/2004 | US6710205 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient |
| 03/23/2004 | US6710191 9β-hydroxytetracyclic taxanes |
| 03/23/2004 | US6710190 3-heteroarylalkyl substituted gaba analogs |
| 03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 03/23/2004 | US6710088 Inorganic ion receptor-active compounds |
| 03/23/2004 | US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 03/23/2004 | US6710075 Compounds having a cyclopentabenzofuran core shown to exhibit potent cytotoxic and cytostatic effects on cancer cell growth and viability |
| 03/23/2004 | US6710071 Such as ((3-4-(difluoro(phenyl)methyl)phenoxyl-3-phenylpropyl)methylamino)acetic acid; for the enhancement of cognition and the treatment of scizophrenia and other psychoses |
| 03/23/2004 | US6710070 Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/18/2004 | WO2004022775A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022550A1 Compound for treatment of anxiety and methods of preparation and use thereof |
| 03/18/2004 | WO2004022533A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |